Targeting gut bugs could revolutionize future drugs, say researcher

Feb 01, 2008

Revolutionary new ways to tackle certain diseases could be provided by creating drugs which change the bugs in people's guts, according to a Perspective article published today in the journal Nature Reviews Drug Discovery.

Trillions of bugs known as gut microbes live symbiotically in the human gut. They play a key role in many of the processes that take place inside the body. Different people have different types of gut microbes living inside them and abnormalities in some types have recently been linked to diseases such as diabetes and obesity.

The authors of the Perspective argue that targeting gut microbes with new drug therapies, rather than concentrating on the mechanisms in the human body which are the current focus of most drug development programmes, could provide an array of uncharted possibilities for fighting disease. Much research is still needed to untangle the precise role played by each different type of bug.

Professor Jeremy Nicholson, one of the authors of the Perspective from the Department of Biomolecular Medicine at Imperial College London, explained: "It's only recently that we've discovered the huge influence that bugs in the gut have on people's health. The exciting thing about this is that it should be easier to create drugs that can change the bugs than it is to re-engineer human cells and signalling pathways inside the body. Also, if we're not interfering with the body's pathways, these drugs should have less toxic side-effects."

Research has already shown that the makeup of an individual's gut microbes is affected by their diet and other environmental factors. A recent study led by scientists from Imperial College showed that it is possible to alter the makeup of bugs in a mouse's gut, affecting their metabolism, using probiotics.

"We already know that external factors such as altering your diet can change the makeup of the bugs in your gut, so these kinds of therapies will mean a more holistic approach to medicine, looking not just at pharmaceutical treatments but also at lifestyle and nutrition. I think that in ten years' time it will be normal for scientists to take gut bugs into consideration when they are creating new medicines," added Professor Nicholson.

Source: Imperial College London

Explore further: Anti-cholinergic drugs impair physical function in elderly patients

add to favorites email to friend print save as pdf

Related Stories

The bug that lost a few genes to become Black Death

May 27, 2014

About 6,000 years ago, a bacterium underwent a few genetic changes. These allowed it to expand its habitat from the guts of mice to that of fleas. Such changes happen all the time, but in this particular ...

Quick ID for water pathogens

Oct 30, 2013

Drinking water flowing from your tap can contain harmful bacteria, viruses and single-cell animals. And most countries do not routinely test for all these bugs. Instead, scientists usually take a water sample ...

Recommended for you

FDA to start regulating lab-developed tests

22 hours ago

(AP)—The Food and Drug Administration announced Thursday it will begin regulating laboratory-developed tests, a growing class of medical diagnostics that have never before been subject to federal oversight.

Determine patient preferences by means of conjoint analysis

Jul 29, 2014

The Conjoint Analysis (CA) method is in principle suitable to find out which preferences patients have regarding treatment goals. However, to widely use it in health economic evaluations, some (primarily methodological) issues ...

User comments : 0